Trial intelligence / Profile preview

Otipax in children with congestive acute otitis media

2015-001496-48Phase 4Completed

Sponsor
Biocodex
Start
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of lidocaine + phenazone, lidocaine and antipyrine in acute otitis media (AOM), sponsored by Biocodex. Primary endpoint: Tympanic membrane appearance by centralized expert reader. Started Jul 2015; status: completed.

02

Drugs

lidocaine + phenazonelidocaineantipyrine
03

Conditions

acute otitis media (AOM)

Beyond the preview

Go deeper on 2015-001496-48.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-001496-48.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call